Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cronos Group Inc. stock logo
CRON
Cronos Group
$2.04
+2.0%
$1.96
$1.60
$2.54
$786.79M1.031.35 million shs1.94 million shs
STADA Arzneimittel Aktiengesellschaft stock logo
STDAF
STADA Arzneimittel Aktiengesellschaft
$110.42
$110.42
$75.15
$115.00
$6.88B0.38180 shsN/A
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
$32.77
+1.0%
$29.95
$23.10
$48.85
$610.28M0.64140,187 shs55,638 shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cronos Group Inc. stock logo
CRON
Cronos Group
0.00%+7.37%+6.81%+19.30%-12.07%
STADA Arzneimittel Aktiengesellschaft stock logo
STDAF
STADA Arzneimittel Aktiengesellschaft
0.00%0.00%0.00%0.00%0.00%
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
0.00%+5.04%+12.86%+28.52%-27.13%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Cronos Group Inc. stock logo
CRON
Cronos Group
2.0281 of 5 stars
0.05.00.00.01.40.02.5
STADA Arzneimittel Aktiengesellschaft stock logo
STDAF
STADA Arzneimittel Aktiengesellschaft
N/AN/AN/AN/AN/AN/AN/AN/A
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
3.4396 of 5 stars
1.02.00.03.32.01.73.1
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cronos Group Inc. stock logo
CRON
Cronos Group
0.00
N/AN/AN/A
STADA Arzneimittel Aktiengesellschaft stock logo
STDAF
STADA Arzneimittel Aktiengesellschaft
0.00
N/AN/AN/A
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
2.00
Hold$36.009.86% Upside

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cronos Group Inc. stock logo
CRON
Cronos Group
$117.61M6.69$0.00 per share4,384.08$2.90 per share0.70
STADA Arzneimittel Aktiengesellschaft stock logo
STDAF
STADA Arzneimittel Aktiengesellschaft
$3.84B1.79$11.12 per share9.93$23.11 per share4.78
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
$854.50M0.71$3.78 per share8.68$27.92 per share1.17
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cronos Group Inc. stock logo
CRON
Cronos Group
$41.08M$0.1315.6968.00N/A39.69%-0.07%-0.07%8/6/2025 (Estimated)
STADA Arzneimittel Aktiengesellschaft stock logo
STDAF
STADA Arzneimittel Aktiengesellschaft
$292.15MN/A0.00N/AN/AN/AN/AN/A
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
$42.03M$1.8218.0111.341.053.98%8.94%6.74%7/22/2025 (Estimated)

Latest STDAF, CRON, and USNA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/22/2025Q2 2025
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
$0.54N/AN/AN/A$225.20 millionN/A
5/8/2025Q1 2025
Cronos Group Inc. stock logo
CRON
Cronos Group
$0.01$0.02+$0.01$0.02$45.44 million$33.62 million
4/22/2025Q1 2025
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
$0.70$0.73+$0.03$0.49$243.08 million$249.54 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Cronos Group Inc. stock logo
CRON
Cronos Group
N/AN/AN/AN/AN/A
STADA Arzneimittel Aktiengesellschaft stock logo
STDAF
STADA Arzneimittel Aktiengesellschaft
N/AN/AN/AN/AN/A
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cronos Group Inc. stock logo
CRON
Cronos Group
N/A
27.80
26.75
STADA Arzneimittel Aktiengesellschaft stock logo
STDAF
STADA Arzneimittel Aktiengesellschaft
2.23
1.54
0.99
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
N/A
2.05
1.51

Institutional Ownership

CompanyInstitutional Ownership
Cronos Group Inc. stock logo
CRON
Cronos Group
8.71%
STADA Arzneimittel Aktiengesellschaft stock logo
STDAF
STADA Arzneimittel Aktiengesellschaft
N/A
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
54.25%
CompanyEmployeesShares OutstandingFree FloatOptionable
Cronos Group Inc. stock logo
CRON
Cronos Group
450385.68 million357.53 millionOptionable
STADA Arzneimittel Aktiengesellschaft stock logo
STDAF
STADA Arzneimittel Aktiengesellschaft
12,50062.34 millionN/ANot Optionable
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
1,70018.62 million18.51 millionOptionable

Recent News About These Companies

USANA Announces the Elevation of Its Opportunity

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Cronos Group stock logo

Cronos Group NASDAQ:CRON

$2.04 +0.04 (+2.00%)
Closing price 07/3/2025 03:16 PM Eastern
Extended Trading
$2.04 0.00 (-0.25%)
As of 07/3/2025 04:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

STADA Arzneimittel Aktiengesellschaft stock logo

STADA Arzneimittel Aktiengesellschaft OTCMKTS:STDAF

$110.42 0.00 (0.00%)
As of 10/24/2022

STADA is a publicly traded, international company with a focus on the healthcare market, especially the pharmaceutical and in particular the generics market.

USANA Health Sciences stock logo

USANA Health Sciences NYSE:USNA

$32.77 +0.32 (+0.99%)
Closing price 07/3/2025 03:30 PM Eastern
Extended Trading
$32.74 -0.03 (-0.08%)
As of 07/3/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.